APA Citatie

Weber, M. S., Prod’homme, T., Youssef, S., Dunn, S. E., Steinman, L., & Zamvil, S. S. (2014). Neither T-helper type 2 nor Foxp3(+) regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity. BioMed Central.

Chicago Style citaat

Weber, Martin S., Thomas Prod’homme, Sawsan Youssef, Shannon E. Dunn, Lawrence Steinman, en Scott S. Zamvil. Neither T-helper Type 2 nor Foxp3(+) Regulatory T Cells Are Necessary for Therapeutic Benefit of Atorvastatin in Treatment of Central Nervous System Autoimmunity. BioMed Central, 2014.

MLA citatie

Weber, Martin S., et al. Neither T-helper Type 2 nor Foxp3(+) Regulatory T Cells Are Necessary for Therapeutic Benefit of Atorvastatin in Treatment of Central Nervous System Autoimmunity. BioMed Central, 2014.